“…As neurological disorders and neurodegenerative diseases, such as a stroke, Alzheimer's disease, and Parkinson's disease tend to become more frequent, the role of neuroprotective agents becomes more important. Bilobalide and ginkgolide B (sesquiterpene lactone), cannabidiol and delta-9-tetrahydrocannabinol (diterpene), catalpol (monoterpene), serofendic acid (diterpene), and lycopene and crocetin (carotenoid) have shown various protective effects against ischemic and glutamatergic neurotoxicity, 6-hydroxydopamine toxicity, oxidative stress, and so on, both in cellular systems in vitro and animal model systems in vivo (Defeudis, 2002;Logani et al, 2000;Jackson et al, 2005;Lastres-Becker et al, 2005;Li et al, 2004;Osakada et al, 2004;Hsiao et al, 2004;Ahmad et al, 2005). Although neuroprotective activity of various terpenoids with varying effectiveness and action mechanisms have been reported as listed above, it is hard to find studies that compare different terpenoids for neuroprotective activity with reference to their structure.…”